CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
1.93
0.17 (9.66%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.26%
After-hours: Aug 15, 2025, 07:54 PM EDT
CytomX Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | 0.59 | 1.09 | 4.38 | -4.32 | 3.20 | 31.16 | 8.70 | -26.32 | -25.81 | -1 | -1.05 | -1.27 | -1.83 | -2.69 | -3.64 | -5.35 | -7.57 |
PEG Ratio | 0.03 | 0.00 | -0.02 | 0.03 | 0.00 | -0.47 | -0.03 | -2.26 | 0.27 | -0.06 | 0.19 | n/a | 0.18 | -0.19 | -0.22 | -0.35 | 0.40 |
PS Ratio | 1.09 | 2.17 | 3.00 | 4.49 | 4.25 | 3.92 | 3.95 | 4.63 | 4.26 | 112.01 | 5.65 | 6.60 | 10.19 | 14.31 | 18.67 | 25.28 | 29.51 |
PB Ratio | 2.21 | -180.93 | -4.28 | -3.62 | -5.57 | -2.2 | -2.03 | -1.35 | -1.15 | -1.24 | 3.36 | 2.46 | 2.56 | 3.16 | 2.94 | 3.14 | 3.23 |
P/FCF Ratio | -2.62 | -4.13 | -4.84 | -5.75 | -6.74 | -4.69 | -5.71 | -4.45 | 10.76 | -67.24 | -2.79 | -3.46 | -4.15 | -8.98 | -10.96 | -14.54 | -15.24 |
P/OCF Ratio | -2.63 | -4.14 | -4.84 | -5.77 | -6.77 | -4.75 | -5.71 | -4.55 | 10.70 | -76.01 | -2.82 | -3.5 | -4.23 | -9.05 | -11.06 | -14.6 | -15.74 |
OCF/S Ratio | -0.41 | -0.52 | -0.62 | -0.78 | -0.63 | -0.83 | -0.69 | -1.02 | 0.40 | -1.47 | -2 | -1.88 | -2.41 | -1.58 | -1.69 | -1.73 | -1.87 |
Debt / Equity Ratio | 0.33 | -20.58 | -0.45 | -0.38 | -0.41 | -0.29 | -0.29 | -0.19 | -0.2 | -0.21 | 0.67 | 0.41 | 0.31 | 0.24 | 0.20 | 0.18 | 0.17 |
Quick Ratio | 1.73 | 1.25 | 1.04 | 1.00 | 1.16 | 1.17 | 1.37 | 1.33 | 1.40 | 1.55 | 2.05 | 2.34 | 2.61 | 2.92 | 2.42 | 2.90 | 4.08 |
Current Ratio | 1.73 | 1.25 | 1.04 | 1.00 | 1.16 | 1.17 | 1.37 | 1.33 | 1.40 | 1.55 | 2.05 | 2.34 | 2.61 | 2.92 | 2.42 | 2.90 | 4.08 |
Asset Turnover | 0.52 | 0.32 | 0.24 | 0.16 | 0.22 | 0.13 | 0.12 | 0.12 | 0.10 | 0.00 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.04 | 0.04 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 0.94 | -41.39 | -0.24 | 0.21 | -0.44 | -0.02 | -0.06 | 0.01 | 0.01 | 0.31 | -0.8 | -0.49 | -0.35 | -0.29 | -0.2 | -0.15 | -0.11 |
Return on Assets | 0.24 | 0.16 | 0.04 | -0.04 | 0.07 | n/a | 0.01 | -0.01 | n/a | -0.1 | -0.1 | -0.09 | -0.08 | -0.08 | -0.06 | -0.05 | -0.04 |
Return on Invested Capital | 0.42 | 0.51 | 0.16 | -0.33 | 0.26 | n/a | 0.02 | -0.05 | -0.02 | -0.24 | -0.18 | -0.15 | -0.12 | -0.11 | -0.08 | -0.06 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.98 | 0.95 | 0.94 | 0.94 | -0.57 | 0.91 | 0.92 | 1.00 | 0.92 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | 0.46 | 0.50 | 0.17 | -0.26 | 0.33 | 0.03 | 0.11 | -0.04 | -0.04 | -28.1 | -1.34 | -1.3 | -1.39 | -1.33 | -1.28 | -1.18 | -0.97 |
Pretax Profit Margin | 0.46 | 0.50 | 0.17 | -0.26 | 0.33 | 0.07 | 0.22 | -0.04 | -0.14 | -29.55 | -1.38 | -1.33 | -1.39 | -1.33 | -1.28 | -1.18 | -0.97 |
Operating Profit Margin | 0.44 | 0.46 | 0.12 | -0.34 | 0.28 | -0.02 | 0.12 | -0.14 | -0.24 | -30.32 | -1.42 | -1.36 | -1.4 | -1.33 | -1.29 | -1.18 | -0.98 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 0.45 | 0.47 | 0.14 | -0.32 | 0.29 | -0.00 | 0.14 | -0.11 | -0.22 | -34.85 | -1.72 | -1.62 | -1.84 | -1.25 | -1.25 | -1.14 | -0.94 |